BERMAN DENNIS N
SEC insider (Form 3/4/5 filer). CIK 0001273858. Director at Inhibikase Therapeutics, Inc. (IKT). 22 reported Form 4/5 transactions since Sep 2024; latest on Jun 30, 2025. Located in ATLANTA, GA.
Companies BERMAN DENNIS N has filed insider reports for
- Inhibikase Therapeutics, Inc. (IKT): Director
BERMAN DENNIS N
CIK: 0001273858
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Inhibikase Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (22 total)
- Jun 30, 2025IKT
Inhibikase Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
108.2K shares- - Feb 14, 2025IKT
Inhibikase Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
39.6K shares- - Jan 21, 2025IKT
Inhibikase Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
21.9K shares- - Jan 21, 2025IKT
Inhibikase Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
6.7K shares- - Jan 21, 2025IKT
Inhibikase Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
3.8K shares- - Jan 21, 2025IKT
Inhibikase Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
6.7K shares- - Jan 21, 2025IKT
Inhibikase Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
30K shares- - Jan 21, 2025IKT
Inhibikase Therapeutics, Inc.
DispositionIndirectStock Option (Right to Buy)
3.8K shares- - Jan 21, 2025IKT
Inhibikase Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
1.1K shares- - Jan 21, 2025IKT
Inhibikase Therapeutics, Inc.
AwardIndirectStock Option (Right to Buy)
6.7K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 30, 2025 | IKT Inhibikase Therapeutics, Inc. | Award Stock Option (Right to Buy) | 108,176 | - | - | Direct |
| Feb 14, 2025 | IKT Inhibikase Therapeutics, Inc. | Award Stock Option (Right to Buy) | 39,620 | - | - | Direct |
| Jan 21, 2025 | IKT Inhibikase Therapeutics, Inc. | Award Stock Option (Right to Buy) | 21,854 | - | - | Direct |
| Jan 21, 2025 | IKT Inhibikase Therapeutics, Inc. | Award Stock Option (Right to Buy) | 6,667 | - | - | Direct |
| Jan 21, 2025 | IKT Inhibikase Therapeutics, Inc. | Award Stock Option (Right to Buy) | 3,780 | - | - | Direct |
| Jan 21, 2025 | IKT Inhibikase Therapeutics, Inc. | Award Stock Option (Right to Buy) | 6,667 | - | - | Direct |
| Jan 21, 2025 | IKT Inhibikase Therapeutics, Inc. | Award Stock Option (Right to Buy) | 30,000 | - | - | Direct |
| Jan 21, 2025 | IKT Inhibikase Therapeutics, Inc. | Disposition Stock Option (Right to Buy) | 3,780 | - | - | Indirect |
| Jan 21, 2025 | IKT Inhibikase Therapeutics, Inc. | Award Stock Option (Right to Buy) | 1,138 | - | - | Direct |
| Jan 21, 2025 | IKT Inhibikase Therapeutics, Inc. | Award Stock Option (Right to Buy) | 6,667 | - | - | Indirect |
1-10 of 22 transactions